Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 3.0 | 4.0 |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 1.81 | 1.95 |
NAV | ₹512.89 | ₹431.00 |
Fund Started | 10 May 2004 | 04 Jun 1999 |
Fund Size | ₹8638.23 Cr | ₹3459.68 Cr |
Exit Load | Exit load of 1% if redeemed within 1 month. | Exit load of 0.50% if redeemed within 15 days |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 36.50% | 46.30% |
3 Year | 19.76% | 24.77% |
5 Year | 27.97% | 29.91% |
1 Year
3 Year
5 Year
Equity | 96.97% | 96.50% |
Cash | 3.03% | 3.50% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
Sun Pharmaceutical Industries Ltd. | 13.52% |
Divi's Laboratories Ltd. | 9.65% |
Lupin Ltd. | 7.61% |
Cipla Ltd. | 5.50% |
Apollo Hospitals Enterprise Ltd. | 5.13% |
Dr. Reddy's Laboratories Ltd. | 5.10% |
Vijaya Diagnostic Centre Ltd. | 4.09% |
Ajanta Pharma Ltd. | 3.36% |
Medplus Health Services Ltd. | 3.23% |
Gland Pharma Ltd. | 3.02% |
Name | Assets |
---|---|
Sun Pharmaceutical Industries Ltd. | 12.87% |
Divi's Laboratories Ltd. | 6.42% |
Cipla Ltd. | 5.68% |
Max Healthcare Institute Ltd. | 5.66% |
Lupin Ltd. | 4.74% |
Lonza Group Ag | 4.39% |
Poly Medicure Ltd. | 4.02% |
Krishna Institute of Medical Sciences Ltd | 3.75% |
Jupiter Life Line Hospitals Ltd. | 3.64% |
Aether Industries Ltd. | 3.33% |
Name | Akshay Sharma | Tanmaya Desai |
Start Date | 01 Dec 2022 | 27 Jun 2011 |
Name
Start Date
Description | The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies. | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. |
Launch Date | 10 May 2004 | 04 Jun 1999 |
Description
Launch Date